The Effect of Bariatric Surgery on Insulin Sensitivity and Energy Metabolism (BARIA-DDZ)

  • STATUS
    Recruiting
  • End date
    Dec 28, 2023
  • participants needed
    450
  • sponsor
    German Diabetes Center
Updated on 28 May 2022
insulin
insulin sensitivity
bariatric surgery
gastric banding
Accepts healthy volunteers

Summary

The purpose of this study is:

  1. To explore to what extent insulin sensitivity, energy metabolism and ectopic lipid storage can be improved by bariatric surgery
  2. To explore to what extent hepatic and muscular disorders of energy metabolism occur in patients with obesity (degree 2-3)
  3. To explore whether the steato liver occurring in patients with obesity (degree 2-3) is associated with the degree of liver inflammation

Description

Insulin resistance strongly relates to ectopic lipid deposition in skeletal muscle and the liver, which correlate with insulin resistance. Lipid metabolites accumulating in skeletal muscle and the liver are thought to impair insulin signalling and thereby reduce glucose uptake and glycogen storage. Insulin resistant humans frequently present with decreased mitochondrial function in skeletal muscle which might contribute to lipid accumulation and the development of insulin resistance. Non-alcoholic liver disease (NAFLD) comprise fatty liver, steatohepatitis and cirrhosis. NAFLD correlate with insulin resistance increased risk for cardiovascular diseases, type 2 diabetes and hepatocellular. The mechanisms leading from fatty liver to steatohepatitis and insulin resistance in the liver are yet unclear. Bariatric surgery relates to surgery for the reduction of body weight. Bariatric surgery frequently leads to normalization of glucose tolerance in previously diabetic humans even before the onset of body weight reduction. The underlying mechanisms are yet unclear. In this study we aim to explore the mechanisms underlying the onset of insulin resistance and steatohepatitis in patients with fatty liver and to identify the mechanisms leading to improved glucose tolerance in humans after bariatric surgery. We test the following hypotheses: increased lipid availability leads to (i) increased lipid oxidation and oxidative stress (ii) accumulation of lipid metabolites that impair insulin signalling (iii) bariatric surgery improves insulin sensitivity by increasing lipid oxidation.

This study will contribute to the understanding of NAFLD and will help to identify new targets for the therapy of diabetes.

Details
Condition Obesity, Diabetes Mellitus, Type 2
Treatment Surgery
Clinical Study IdentifierNCT01477957
SponsorGerman Diabetes Center
Last Modified on28 May 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

Aged ≥ 20 years- ≤ 70 years
BMI 20- 25 kg/m 2 normal- weight group
BMI 35- 39,9 kg/m 2 (Obesity grade 2)
BMI >40 kg/m 2 (Obesity grade 3)

Exclusion Criteria

Autoimmune or Immune disorder diseases (Leukozyten < 5000/µl
Acute illness 2 weeks before start of examination
Renal insufficiency (Kreatin > 1,5 mg/dl)
Heart disease, condition after heart attack
Anemia (Hb <12g/l, controlled before every day of examination) or blood donations 4weeks before examination
Participation in another trial within the last 2 weeks
Pharmacological- immunotherapy (Cortisol, Antihistaminika, ASS)
Glitazone Therapy
Thyroid disorders
Pregnancy, Lactation, Menstruation
Smoking cigarettes, Alcohol- and drug abuse
Psychiatric disorders
Risk for/ or diagnosed HIV/ AIDS or Hepatitis B/C
Liver disease, which are not caused by non- alcoholic steato- hepatitis
Working on night shifts or irregular rhythm of night- day
Impaired wound healing or clotting disorders
Allergic reaction to local anesthetics
Malignant cancer
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note